Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Preclinical CNS Models are essential tools for studying the complex mechanisms of central nervous system (CNS) disorders and for developing and testing potential therapeutic strategies. At Naason Science, we specialize in advanced preclinical models that simulate a range of CNS diseases, including neurodegenerative conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD), as well as other disorders like Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS)
Our models are designed to replicate key pathological and behavioral features of CNS diseases, enabling researchers to explore disease progression, molecular mechanisms, and the efficacy of potential treatments. We offer both toxin-induced and transgenic models to suit diverse research needs, providing reliable platforms for understanding neurodegeneration, neuroinflammation, and neuronal dysfunction.
By utilizing cutting-edge in vivo and in vitro techniques, our CNS models help bridge the gap between basic research and clinical application, accelerating the development of novel therapeutics that can transform patient care.
© 2024 Naason Science Inc. All rights reserved.